InspireMD Announces Pricing of $37.5 Million Public Offering

InspireMD priced an underwritten public offering expected to generate approximately $37.5 million in gross proceeds. The offering includes 7,342,308 common shares, pre-funded warrants for 50,350,000 shares, and accompanying common warrants for 43,269,231 shares. Proceeds are intended to support research and development, sales and marketing, working capital, and general corporate purposes; closing is expected around November 16, 2026, subject to customary conditions. Lake Street Capital Markets is the sole book-running manager.